CTMX

2.0300.98%
AV

Alejandra Veronica Carvajal

Chief Legal Officer

Ms. Alejandra Veronica Carvajal, J.D, is Chief Legal Officer of CytomX Therapeutics, Inc. from August 2026. She had been Senior Vice President and Chief Legal Officer of Mersana Therapeutics, Inc. since April 2021 and served as its Secretary. She had been the Chief Legal Officer, General Counsel & Secretary at Momenta Pharmaceuticals, Inc. since October 2018 until March 2021. From June 2017 to October 2018, Ms. Carvajal served as the Vice President, Deputy General Counsel of Momenta. Ms. Carvajal served as General Counsel and Vice President at Cerulean Pharma Inc. since September 29, 2014 to June 2017. Ms. Carvajal joined Cerulean after a decade-long tenure with Millennium Pharmaceuticals, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited focused on oncology, from 2004 to 2014, where she held a variety of legal positions of increasing seniority: The Takeda Oncology Company, as Associate General Counsel, where she served as a Strategic Advisor to the research and development, business development, manufacturing and commercial functions. Prior to joining Millennium, she began her legal career in private practice and was an Attorney with the law firms Day, Berry & Howard and Hill & Barlow. Ms. Carvajal received her B.A. cum laude from Harvard University and her J.D. cum laude from Georgetown University Law Center. She is a member of the Commonwealth of Massachusetts Bar.

Positions